Back
Matinas BioPharma Holdings Vs. Simulations Plus Industry Stock Comparison
Sell
38
MTNB
Matinas BioPharma Holdings
Last Price:
$0.63
Seasonality Move:
-18.9%
Buy
52
SLP
Simulations Plus
Last Price:
$35.49
Seasonality Move:
1.33%
Sell
38
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy, Sell or Hold?
-
The current Matinas BioPharma Holdings [MTNB] share price is $0.67. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Simulations Plus (SLP)
is a Buy
Is Simulations Plus a Buy, Sell or Hold?
-
The current Simulations Plus [SLP] share price is $35.50. The Score for SLP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
SLP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MTNB Stock Price Chart
What is Matinas BioPharma Holdings's stock price today?
-
The Matinas BioPharma Holdings share price today is $0.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MTNB is experiencing buying pressure, which is a positive indicator for future bullish movement.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $35.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLP is experiencing slight buying pressure.
MTNB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 64.51 | Buy |
Chaikin Money Flow: | 112759 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.54 - 0.6) | Buy |
Bollinger Bands (100): | (0.52 - 0.64) | Buy |
SLP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.28 | Buy |
Relative Strength Index (14 RSI): | 70.3 | Buy |
Chaikin Money Flow: | 4272 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.83 - 33.13) | Buy |
Bollinger Bands (100): | (26.49 - 33.91) | Buy |
MTNB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.59 | Buy |
20-day SMA: | 0.56 | Buy |
50-day SMA: | 0.57 | Buy |
200-day SMA: | 2.48 | Sell |
8-day EMA: | 0.6 | Buy |
20-day EMA: | 0.58 | Buy |
50-day EMA: | 0.6 | Buy |
200-day EMA: | 2.77 | Sell |
SLP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.2 | Buy |
20-day SMA: | 29.4 | Buy |
50-day SMA: | 29.24 | Buy |
200-day SMA: | 32.23 | Buy |
8-day EMA: | 33.99 | Buy |
20-day EMA: | 31.13 | Buy |
50-day EMA: | 29.84 | Buy |
200-day EMA: | 32.71 | Buy |
Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.56 per share, and a decrease next year of $2.50 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.11 per share, an increase this year of $0.56 per share, and an increase next year of $0.14 per share.
Matinas BioPharma Holdings Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Simulations Plus Technical Analysis
Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |